2021-03-31-accounts - National Confidential Enquiry Into Patient Outcome And Death

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

The Trustees	The Trustees	have made the following professional appointments:	have made the following professional appointments:
Solicitor:			H Montlake 8c Co, 198 High Street, llford, Essex IG1 1LX
Auditor:			Kreston Reeves, Montague Place, Quayside, Chatham Maritime,		Chatham,			ME4
			4QU
Bankers:			CAF Bank Limited, 25 Kings Hill Avenue,	Kings Hill, West Mailing,	Kent ME194JQ
			CCLA Investment Management Limited,	80Cheapside, London	EC2V 6DZ
			Virgin Money, Jubilee House, Gosforth,	Newcastle upon Tyne, NE3		4PL
			The Charity Bank Limited, Fosse House,	182 High Street, Tonbridge,		TN9 1BE
			Nationwide Building Society, Nationwide	House, Pipers Way, Swindon,			SN38 1NW
Stockbrokers:			Quilter Cheviot Investment Management,	Senator House, 85 Queen Victoria St,
			London EC4V 4AB
Insurance	Brokers:		Insurance Services (Surrey) Ltd, PO Box	1533,Waking, GU22 2RY
			Secondsight, Foster Denovo Group, 2 Hamm Moor Lane, Weybridge,			Surrey		KT15	2SA
The following		key senior	members of staff are responsible for the day-to-day activities		of	the	charity		who
together	with	the Trustees	form the key management personnel of	the charity:
Dr Marisa	Mason		Chief Executive 8~ Company Secretary
Dr Neil Smith			Clinical Researcher 5 Deputy Chief Executive

Association ofAnaesthetists	Association ofAnaesthetists			Royal College of Ophthalmologists	Royal College of Ophthalmologists
Dr M Nathanson —demitted		5 November	2020	Vacancy
Dr W Fawcett —appointed	5	November	2020
Association ofSurgeons ofGreat Britain			and Ireland	Royal College of Paediatrics	and Child Health
Mr M Lansdown				Drl Doughty
Royal College of Emergency		Medicine		Royal College of Physicians	of London
Dr A Boyle				Dr M Kumwenda, Dr H Skene and Dr A Gibson
Faculty of Dental Surgery				Royal College of Physicians	and Surgeons of Glasgow
MrJ Dhanda				Dr M McKirdy
Faculty of Intensive Care	Medicine			Royal College of Physicians	of Edinburgh
Dr J Butler				Dr J MacLeod
Lay Representatives				Royal College of Psychiatrists
Mr S Barasi —demitted 9	July 2020			Dr J Carlile —demitted 28January 2021
Royal College ofAnaesthetists				Royal College of Radiologists
Dr CCarey and Dr K Ramchandaran				Prof R McWilliams
Royal College ofGeneral	Practitioners			Royal College of Pathologists
Vacancy				Dr L Igali
Royal College of Nursing				Royal College ofSurgeons of Edinburgh
Dr N Ashby				Miss A Paisley
Royal College ofObstetricians		and Gynaecologists		Royal College ofSurgeons of England
Dr T Hillard				Miss SVig

Eleven consultants	been on secondment	to NCEPOD as Clinical Co-ordinators
March 2021, committing	to between one and	two sessions per week,
Dr M Docherty	Liaison Psychiatry
Dr A Goodwin	Anaesthesia and Critical Care
Dr M Juniper	Respiratory Medicine
Dr K Malbon	Paediatrics
Dr S McPherson	Radiology
Dr A Michalski	Paediatric Oncology
Mr M Sinclair	General Surgery
Dr V Srivastava	Acute Medicine
Dr A Tavare	General Practice
Dr K Wilkinson	Paediatric Anaesthesia
Mr J Abercrombie	Surgery

1.	Form the	Study Advisory	6.Test data collection methods	11.Data analysis
2.	Write the	protocol	7, Meet with the SAG for a second time	12.Write the report
3,	Design the questionnaires		8. Final protocol to Steering Group and HQIP	13.Design the report
4.	Advertise	the study	9.Start data collection	14.Publish the report
5.	Advertise	for Reviewers	10.Run Reviewer meetings

Area ofstudy:				Milestone reached:
Dysphagia in Parkinson's		Disease		Report being written
Physical healthcare	in mental		health hospitals	Data being collected
Epilepsy				Data being collected
Community acquired	pneumonia			Study being developed
Crohn's disease				Study being developed
Transition between	child	and	adult healthcare	Study being developed
Endornetriosis				Study being developed
End of life care				Study being developed
Testicular torsion				Study being developed
Natural deaths in prison				Study being developed

				Total	Total
			Notes	2021	2020
				f	f
INCOME FROM:
Donations				12,000	132,300
Charitable activities				1,154,353	1,216,461
Investments				10,303	18,139
TOTAL INCOME				1,176,656	1,366,900
EXPENDITURE ON:
Charitable activities				972,248	1,278,134
TOTAL EXPENDITURE				972,248	1,278,134
Net gain/(loss) on	investments			34,820	(53,061)
NET INCOME				239,228	35,705
NET MOVEMENT	IN FUNDS			239,229	35,705
RECONCILIATION	OF FUNDS
Fund balances brought		forward
at 1April 2020				1,276,343	1,240,638
FUND BALANCES	CARRIED FORWARD
AT31MARCH 2021				1,515,571	1,276,343

		Notes	2021	2020
			f	f
FIXED ASSETS
Tangible assets			3,292	7,489
Investments			212,538	151,957
			215,830	159,446
CURRENT ASSETS
Debtors			355,757	361,396
Cash at bank and in	hand		1,091,609	770,598
			1,447,366	1,131,994
LIABILITIES
Creditors: Amounts	falling due within one year	10	{147,625)	(15,097)
NET CURRENT ASSETS			1,299,741	1,116,897
TOTAL ASSETS LESS	CURRENT LIABILITIES
& NET ASSETS			1,515,571	1,276,343
THE FUNDS OF THE	CHARITY
Unrestricted income	funds
General Fund			1,495,571	1,256,343
Designated Premises	Fund		20,000	20,000
TOTAL CHARITY FUNDS			1,515,571	1,276,343

				Notes	2021	2020
					f	f
Cash flows from operating	activities
Net cash provided by operating		activities		13	338,206	122,131
Cash flows from investing	activities
Interest from investments					10,303	18,139
Purchase oftangible fixed	assets				(1,737)	(6,634)
Receipts from sale of investments					174,875	38,055
Purchase ofinvestments					(200,637)	(28,125)
Net cash (outflow) inflow	from	investing	activities		(17,196)	21,415
Increase (decrease) in cash for the year					321,011	143,546
Cash brought forward					770,598	627,052
Cash carried forward
					1,091,609	770,598

			Total	Total
			2021	2020
			f	f
DONATIONS:
Donated services			12,000	132,300
			12,000	132,300
INCOME FROM CHARITABLE ACTIVITIES —DESIGNING AND RUNNING			CONFIDENTIAL SURVEY
Healthcare Quality	Improvement		1,091,234	1,178,086
Partnership (HQIP)
Private hospitals			49,800	32,050
Conference, exhibition		and other
income sources			13,319	6,325
			1,154,353	1,216,461
INVESTMENT INCOME
Dividends			8,161	13,907
Bank interest receivable		on
short term cash deposits			2,142	4,232
			10,303	18,139

				Total	Total
				2021	2020
				E	E
Support costs (note 5)				244,142	290,704
Direct staff costs (note 6)				515,358	588,651
Other direct expenditure:
Staff healthcare, training,	and recruitment			1,441	385
Clinical co-ordinators secondments				177,881	136,244
Clinical reviewers (donated	services)			12,000	132,300
Clinical co-ordinators, reviewers,		and
staff expenses				6,508	60,566
Consultancy				2,009	388
Temporary staff costs					427
Conference, exhibition, and meetings
expenses				(2,325)	10,703
Operating lease rentals:
Plant and machinery				5,666	5,666
Other printing and report	production		costs	5,536	35,277
Postage and distribution				4,032	5,346
Cardiff University —Child Health project					11,477
				972,248	1,278,134

			Support	Governance	Total	Total
			costs	costs	2021	2020
			f	f	f	f
5.	SUPPORT AND GOVERNANCE	COSTS
	Staff costs (note 6)			691	691	1,490
	Other expenditure:
	Operating lease rentals:
	Land and buildings		136,747		136,747	145,620
	Other premises costs		15,854		15,854	20,810
	Auditors' remuneration:
	Audit fees			10,288	10,288	10,000
	Bookkeeping and payroll costs		10,920	166	11,086	26,217
	Public relations		447	7	454
	Computer expenses		30,660	467	31,127	30,111
	Insurance		17,370	265	17,635	17,077
	Sundry expenses		4,183	64	4,247	13,063
	Telephone		4,468	68	4,536	2,832
	Office costs		5,319	81	5,400	10,877
	Steering Group expenses					3,837
	Trustee expenses					3,042
	Depreciation —owned assets		5,849		5,934	5,640
	Bank charges		143		143	88
			231,960	12,181	244,142	290,704

EAR COMPARATIVE
		Support	Governance	Total	Total
		costs	costs	2020	2019
		f	E	f	E
SUPPORT AND GOVERNANCE	COSTS
Staff costs (note 6)			1,490	1,490	1,462
Other expenditure:
Operating lease rentals:
Land and buildings		145,620		145,620	113,972
Other premises costs		20,810		20,810	16,919
Auditors' remuneration:
Audit fees			10,000	10,000	10,668
Bookkeeping and payroll costs		26,138	79	26,217	27,375
Computer expenses		30,021	90	30,111	24,159
Insurance		17,026	51	17,077	16,186
Sundry expenses		13,024	39	13,063	9,396
Telephone		2,824	8	2,832	4,087
Office costs		10,844	33	10,877	11,761
Steering Group		3,837		3,837	2,930
Trustee expenses			3,042	3,042	2,576
Depreciation —owned assets		5,623	17	5,640	5,237
Bank charges		88		88	88
		275,855	14,849	290,704	246,816

						2021	2020
6.	STAFF COSTS
						No.	No.
	The average monthly	number of persons employed			by
	NCEPOD during the year		(excluding Trustees) was:
	Designing and running	of confidential		surveys		14	14
	Staff costs for the above		persons:
	Wages and salaries					434,049	492,875
	Social security costs					38,975	50,210
	Pension costs					43,025	47,055
						516,049	590,141
	Staff costs are allocated		in the financial	statements,	as follows:
	Designing and running	ofconfidential		surveys —unrestricted		515,358	588,651
	Governance costs					691	1,490
						516,049	590,141

				Computer	Fixtures &
				equipment	fittings	Total
				E	f	E
Cost:
1April 2020				49,303	15,033	64,336
Additions				1,737		1,737
Disposals				(20,689)		(20,689)
31March	2021			30,351	15,033	45,384
Depreciation:
1April 2020				42,361	14,486	56,847
Charge in	the year			5,536	398	5,934
Depreciation on disposal				(20,689)		(20,689)
31March	2021			27,208	14,884	42,092
Net book	value:
31March	2021			3,143	149	3,292
31March	2020			6,942	547	7,489
					2021	2020
INVESTMENTS
Listed investments:
Opening balance at 1April					151,957	214,903
Additions	at cost				200,637	39,997
(inc cash	account movement)					(11,872)
Disposals					(174,875)	(38,010)
Realised gains/losses		in	investments		22,918
Unrealised	gains/losses		on investments		11,902	(53,061)
Market value at 31March					212,538	151,957

						2021	2020
	Analysis ofinvestment holdings
	Invesco Perpetual	Enhanced	ln	Ld	Ord (IPE)		44,412
	Balfour Beatty curn cnv pref		(BBYB)				33,828
	CQS New City High	Yield Fund		Ltd	Ord Npv (NCYF)		27,730
	QC Global income	and Growth		Fund		212,538	43,774
	Cash						2 213
	Market value at 31March					212,538	151,957
	DEBTORS
	Amounts failing due within		one year:
	Trade debtors					287,351	292,841
	Other debtors					25,645	28,050
	Prep ayments					42,761	40,505
						355,757	361,396
10.	CREDITORS
	Amounts falling due within		one year:
	Trade creditors					35,268	2,008
	Accruals and deferred income					112,357	13,089
						147,625	15,097
	Deferred income
	Deferred income at 1April		2020
	Resources deferred during		the	year		88,000
	Amounts released	from previous			years
						88,000

			1April	Income	Expenditure	Gain on	31March
			2020			Investment	2021
			f	f	f	f	f
Unrestricted		income	funds:
General	Fund		1,256,343	1,176,656	(972,247)	34,820	1,495,571
Designated		Premises	20,000				20,000
Fund
			1,276,343	1,176,656	(972,247)	34,820	1,515,571

				1	April	Income	Expenditure	Loss on	31March
					2019			Investment	2020
					f			f	f
Unrestricted		income	funds:
General	Fund			1,220,638		1,366,900	(1,278,134)	(53,061)	1,256,343
Designated		Premises		20,000					20,000
Fund
				1,240,638		1,366,900	(1,278,314)	(53,061)	1,276,343
NALYSIS	OF	NET ASSETS BETWEEN FUNDS
						Fixed asset	Tangible fixed	Net current	Total
						investments	assets	assets
						f	f	f
Unrestricted		income	funds:
General	Fund					212,538	3,292	1,279,741	1,495,571
Designated		Premises	Fund					20,000	20,000
NET ASSETS		AT 31MARCH		2020		212,538	3,292	1,299,741	1,515,571
						Fixed asset	Tangible fixed	Net current	Total
						investments	assets	assets
						f	f	f
Unrestricted		income	funds:
General	Fund					151,957	7,489	1,116,897	1,276,343
Designated		Premises	Fund					20,000	20,000
NET ASSETS		AT31MARCH		2019		151,957	7,489	1,136,897	1,296,343

			2021	2020
			f	f
Net income for the	year		239,228	35,705
Depreciation (note	7)		5,934	5,640
(Gains)/loss on investments			(34,820)	53,061
Interest from investment			(10,303)	(18,139)
Decrease (Increase)	in debtors		5,639	51,471
(Decrease) increase	in creditors		132,528	(5,607)
Net cash from oper	ating	activities	338,206	122,131

		2021			2020
		Land 5 Building	Equipment	Land 8 Building		Equipment
	Within 1year	f142,000	f5,606	f142,000		f5,608
	Within 2-5 years	f71,000	f1,402	f213,000		f7,008
	Total	f213,000	f7,008	f355,000		f12,616
15.	NET DEBT RECONCILIATION
		At 1	April 2020	Cash flows	At 31March 2021
			f
	Cash at bank and in hand		770,598	321,011		1,091,609
	Debt
	Total		770,598	321,011		1,091,609
16.	ANALYSIS OF CASH AND CASH EQUIVALENTS
			2021	2020
			f	f
	Cash in hand		1,091,609	1,091,609
	Total cash and cash equivalents		1,091,609	1,091,609